Aldeyra The (ALDX) vs Cingulate Inc. (CING)
A side-by-side comparison of Aldeyra The and Cingulate Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALDX
Aldeyra The
$0.92HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CING
Cingulate Inc.
$4.75HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ALDX vs CING
growth of $100 · dividends reinvested · last 5yALDX -86.6% (-33.1%/yr)CING -99.6% (-66.1%/yr)ALDX compounded faster over this window
Log scale — wide-divergence pair
ALDX CING
ALDX vs CING: by the numbers
- •CING is the larger company ($64M vs $56M market cap).
Metrics side by side
Valuation
| Metric | ALDX | CING |
|---|---|---|
| P/B ratio | 1.47 | 2.73 |
| EV / EBITDA | N/A | 0.21 |
Profitability
| Metric | ALDX | CING |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -60.85% | -122.71% |
| ROIC | -63.52% | -83.74% |
Growth (annualized)
| Metric | ALDX | CING |
|---|---|---|
| Total return CAGR (5Y) | -36.54% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.